Impact of regorafenib in the clinical practice and identification of second-line treatment orphan patients

Authors :: Ernest Belmonte
Jordi Bruix
Anna Darnell
M. Reig
Neus Llarch
Marco Sanduzzi Zamparelli
Alejandro Forner
Álvaro Díaz-González
L.G. Da Fonseca
Josep Corominas
Loreto Boix
Gemma Iserte
C. Ayuso
Victor Sapena
Source :: Journal of Hepatology. 68:S205-S206
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Clinical Practice
Oncology
medicine.medical_specialty
chemistry.chemical_compound
Second line treatment
Hepatology
chemistry
business.industry
Internal medicine
Regorafenib
medicine
Identification (biology)
business

Full Text Access

Tools